Vidissimo s.r.o.
- Address
- Halalovka 2927/63, 911 08 Trenčín, Slovakia
Vidissimo s.r.o. - Pediatric Ophthalmology Research
Vidissimo s.r.o. is a specialized clinical research center focused on pediatric ophthalmology and the treatment of visual disorders in children. The center demonstrates particular expertise in conducting long-term, controlled studies evaluating innovative therapeutic approaches for progressive eye conditions affecting the pediatric population.
- Myopia progression control in children
- Long-term ophthalmic pharmaceutical interventions
- Pediatric refractive disorder management
The facility is actively involved in phase III clinical trials investigating low-dose atropine therapy for controlling myopia progression in pediatric subjects. Their research infrastructure supports multi-year, placebo-controlled studies that assess both safety and efficacy outcomes, contributing to the development of evidence-based treatments for childhood vision disorders that may impact long-term ocular health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vidissimo s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Randomized Double-Masked Placebo-Controlled Study of Atropine Sulfate 0.01% in Pediatric Myopia Progression | Ocumension (Hong Kong) Ltd. | Phase III | Not Recruiting | May 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atropine Sulfate | 1 | Unknown | 2022-05-27 | 2022-05-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.